WhiteCM.Pharmacists have the stats but no provider status: now may be our moment. Ann Pharmacother. 2022. doi:10.1177/10600280211036160.
2.
HammondRWDoleEJ.The pharmacist clinician: prescriptive authority in New Mexico. JMCP. 1996;2(5):594-596. doi:10.18553/jmcp.1996.2.5.594.
3.
PhamNYTYonCMAndersonJR, et al. Awareness and perceptions of advanced practice pharmacists among health care providers in New Mexico. J Am Pharm Assoc (2003). 2021;61(1):101-108. doi:10.1016/j.japh.2020.10.001.
4.
HaleJCMurawskiMMIvesTJ. Perceived successes and challenges of clinical pharmacist practitioners in North Carolina. J Am Pharm Assoc (2003). 2013;53(6):640-643. doi:10.1331/JAPhA.2013.12184.
IHS Markit Ltd. The Complexities of Physician Supply and Demand: Projections From 2019 to 2034. Washington, DC: Association of American Medical Colleges; 2021.
ElnahalSMClancyCMShulkinDJ.A framework for disseminating clinical best practices in the VA health system. JAMA. 2017;317(3):255-256. doi:10.1001/jama.2016.18764.
9.
KnappKKPaavolaFGMaineLLSorofmanBPolitzerRM.Availability of primary care providers and pharmacists in the United States. J Am Pharm Assoc (Wash). 1999;39(2):127-135. doi:10.1016/s1086-5802(16)30486-7.
